Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…
HOME > BUSINESS
BUSINESS
- D. Western Therapeutics Acquires Exclusive License to Corneal Endothelial Therapeutics from Doshisha Univ.
May 10, 2016
- Transfer of Vaccine, Blood Biz under Negotiation, All Directors to Exit in June: Kaketsuken
May 9, 2016
- Ex-Ranbaxy Shareholders Ordered to Pay 56 Billion Yen to Daiichi Sankyo
May 9, 2016
- Shingo Iwamoto to Lead Aspen Japan
May 9, 2016
- Halaven Approved for Advanced Liposarcoma in Europe: Eisai
May 9, 2016
- Brintellix Renamed Trintellix to Curb Name Confusion in US
May 9, 2016
- Ono Ups FY2015 Earnings Forecast on Brisk Opdivo Sales
May 9, 2016
- Sales Rep Survey - Part 2: Drug Makers Exploring Viable Roles amid Govt’s Community-Based Care Initiative
May 6, 2016
- Sales Rep Survey - Part 1: Number of Reps at Foreign Drug Makers Declines Sharply; Down by 330 at GSK
May 2, 2016
- 53 Drug Makers Hire 200 Less New Grads in FY2016, Japan Firms See Hefty Drop: Jiho Tally
April 28, 2016
- Kenji Sukeno to Become New Fujifilm Holdings President
April 28, 2016
- Nogimori to Bow Out as Astellas Chairman
April 28, 2016
- Kaken Licenses Severe Burn Treatment from Israeli Firm
April 27, 2016
- Biogen Eyes Simultaneous Filings in Japan, US, Europe for Alzheimer’s Drug Aducanumab
April 27, 2016
- Harvoni Most Prescribed Drug at Acute Hospitals in October-December
April 27, 2016
- Chugai, Hiroshima Univ. Spinoff Join Hands in Cartilage Regeneration
April 26, 2016
- Boehringer Japan’s Ethical Drug Sales Tick Up 2% in 2015
April 26, 2016
- Novartis Seeks Add’l Indications for Ilaris in Japan
April 26, 2016
- Novartis Looks to Harness Big Data for Indication Expansions: Global Medical Chief
April 26, 2016
- MSD, Sanofi to End RotaTeq, Heptavax Copromotion in Japan
April 25, 2016
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…